scholarly journals Interesterification of a commonly consumed palm-based hard fat blend does not affect postprandial lipoprotein metabolism in healthy older adults

2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
Wendy Hall ◽  
Charlotte Mills ◽  
Robert Gray ◽  
Scott Harding ◽  
Barbara Fielding ◽  
...  

AbstractInteresterified (IE) fats are widely used to replace partially-hydrogenated fats as hard fats with functional and sensory properties needed for spreads/margarines, baked goods, and confectionary, while avoiding the health hazards of trans fats. Detailed mechanistic work to determine the metabolic effects of interesterification of commonly-consumed hard fats has not yet been done. Earlier studies using fats less commonly consumed have shown either neutral or a lowering effect on postprandial lipaemia. We investigated postprandial lipaemia, lipoprotein remodelling, and triacylglycerol-rich lipoprotein (TRL) fraction apolipoprotein concentrations following a common IE blend of palm oil/kernel fractions versus its non-IE counterpart, alongside a reference monounsaturated (MUFA) oil. A 3-armed, double blind, randomized controlled trial (clinicaltrials.gov NCT03191513) in healthy adults (n = 20; 10 men, 10 women) aged 45–75 y, assessed effects of single meals (897 kcal, 50 g fat, 16 g protein, 88 g carbohydrate) on postprandial plasma triacylglycerol (TAG) concentrations, lipoprotein profiles, and TRL fraction apolipoprotein B48 and TAG concentrations. Test fats were IE 80:20 palm stearin/palm kernel fat, the equivalent non-IE fat, and a high-MUFA reference oil (rapeseed oil, RO). Blood was collected at baseline and hourly for 8 h. Linear mixed modelling was performed, adjusting for treatment order and baseline values (ver. 24.0; SPSS Inc., Chicago, IL, USA). Total 8 h incremental area under the curves (iAUC) for plasma TAG concentrations were lower following IE and non-IE compared with RO (mean difference in iAUC: non-IE vs. RO -1.8 mmol/L.h (95% CI -3.3, -0.2); IE vs. RO -2.6 mmol/L.h (95% CI -5.3, 0.0)), but iAUCs for IE and non-IE were not significantly different. There were no differences between IE and non-IE for chylomicron fraction apoB48 concentrations nor TAG:apoB48 ratio. No differences were observed between IE and non-IE for lipoprotein (VLDL, HDL, LDL) particle size or sub-class particle concentrations. However, LDL particle diameters were reduced at 5 and 6 h following IE vs RO (P < 0.05). XXL- (including chylomicron remnants and VLDL particles), XL- and L-VLDL particle concentrations (average diameters > 75, 64, and 53.6 nm respectively) were higher following IE and non-IE vs. RO at 6 h (P < 0.05) and 8 h postprandially (P < 0.005–0.05). In conclusion, both IE and non-IE palmitic acid-rich fats generated a greater preponderance of pro-atherogenic large TRL remnant particles in the late postprandial phase relative to an oleic acid-rich oil. However, the process of interesterification did not modify postprandial TAG response or lipoprotein metabolism.

2006 ◽  
Vol 154 (1) ◽  
pp. 69-74 ◽  
Author(s):  
Helga Á Sigurjónsdóttir ◽  
Josef Koranyi ◽  
Magnus Axelson ◽  
Bengt-Åke Bengtsson ◽  
Gudmundur Johannsson

Objective: In the past years the interaction of GH and 11βhydroxysteroid dehydrogenase (11βHSD) in the pathogenesis of central obesity has been suggested. Design: We studied the effects of 9 months of GH treatment on 11βHSD activity and its relationship with body composition and insulin sensitivity in 30 men with abdominal obesity, aged 48–66 years, in a randomised, double-blind, placebo-controlled trial. Methods: Urinary steroid profile was used to estimate 11βHSD type 1 and 2 (11βHSD1 and 11βHSD2) activities. Abdominal s.c. and visceral adipose tissues were measured using computed tomography. Glucose disposal rate (GDR) obtained during a euglycaemic–hyperinsulinaemic glucose clamp was used to assess insulin sensitivity. Results: In the GH-treated group the 11βHSD1 activity decreased transiently after 6 weeks (P < 0.01) whereas 11βHSD2 increased after 9 months of treatment (P < 0.05). Between 6 weeks and 9 months, GDR increased and visceral fat mass decreased. Changes in 11βHSD1 correlated with changes in visceral fat mass between baseline and 6 weeks. There were no significant correlations between 11βHSD1 and 11βHSD 2 and changes in GDR. Discussion: The study demonstrates that short- and long-term GH treatment has different effects on 11βHSD1 and 11βHSD2 activity. Moreover, the data do not support that long-term metabolic effects of GH are mediated through its action on 11βHSD.


1996 ◽  
Vol 42 (4) ◽  
pp. 415-421 ◽  
Author(s):  
TIMOTHY M. E. DAVIS ◽  
LAWRENCE G. DEMBO ◽  
SALLY A. KAYE-EDDIE ◽  
BENJAMIN J. HEWITT ◽  
ROBERT G. HISLOP ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Scott Harding ◽  
Wendy Hall ◽  
Charlotte Mills ◽  
Barbara Fielding ◽  
Robert Gray ◽  
...  

Abstract Objectives Altering the structure of lipids by interesterification is largely replacing partial hydrogenation in the production of solid form vegetable-based fats. While proposed to be much healthier than the trans-fat containing alternatives, very little mechanistic work has been done to determine how these interesterified (IE) fats act in the human body. This study aimed to describe the physiological handling of commonly consumed IE fats during and after digestion compared to a non-IE equivalent and a control oil. Methods In a randomized, double-blinded controlled trial, healthy adults (n = 20) aged 45–75 years were assessed for postprandial triglyceride (TG) responses following consumption of 3 test meals (897 kcal, 50 g fat, 16 g protein, 88 g carbohydrate). Each meal contained 50 g of IE fat (80:20 palm stearin/palm kernel fat), the equivalent non-IE fat, or high-monounsaturated oil (canola oil, CO). A subsample of the study group (n = 9) consumed 75 mg of 1–13C glyceryl tripalmitate to trace the metabolic fate of the saturated fats consumed. Blood and breath samples were collected at baseline, and hourly thereafter for 8 h. Samples were analyzed for 13C:12C ratio by isotope ratio mass spectrometry and expressed as % dose recovered (PDR). Results No differences were observed for palmitate oxidation as measured by PDR in breath CO2. Similarly, no difference in PDR of plasma 13C-palmitate in the postprandial period was observed between IE or non-IE fats (P = 0.439). Recovery of 13C-palmitate was ∼2.5-fold higher for the CO versus non-IE and IE treatments (P < 0.0001). We speculate this difference was due mainly to the differences in total solid fats at body temperature (37°C) and possibly the higher 13C-palmitate: total palmitate ratio in the CO meal. The levels of solid fat at 37°C were 21%, 16% and 0% for non-IE, IE and CO, respectively. As a function of the total palmitate found in the 50 g of fats consumed, non-IE, IE and CO were labelled with 13C palmitate at 0.26%, 0.26%, and 2.3%, respectively. While it is unlikely tracer enrichment was responsible, both factors may have collectively contributed to the higher isotope recovery in the CO meal. Conclusions Rates of palmitate absorption and oxidation were not affected by interesterification. The degree of saturation likely affect absorption due to the proportion of solid fat at body temperature. Funding Sources BBSRC DRINC (UK). Supporting Tables, Images and/or Graphs


1996 ◽  
Vol 15 (2) ◽  
pp. 94-96 ◽  
Author(s):  
M.M. Berger ◽  
F. Spertini ◽  
A. Shenkin ◽  
M.J. Reymond ◽  
C. Schindler ◽  
...  

2017 ◽  
Vol 5 (8) ◽  
pp. 597-609 ◽  
Author(s):  
John R Petrie ◽  
Nishi Chaturvedi ◽  
Ian Ford ◽  
Martijn C G J Brouwers ◽  
Nicola Greenlaw ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document